The countdown to type 1 diabetes: when, how and why does the clock start?
Ziegler AG
Diabetologia. Pub. online 26 May 2023.
Leggi
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
Pennells L, Kaptoge S, Bleken H, et al.
Eur Heart J. Pub. online 29 May 2023.
Leggi
Dapagliflozin and diuretic utilization in heartfailure with mildly reduced or preserved ejection fraction: the DELIVER trial
Chatur S, Vaduganathan M, Claggett B, et al.
Eur Heart J. Pub. online 23 May 2023.
Leggi
Exercise training, dietary intervention, or combined interventions and their effects on lipid profiles in adults with overweight and obesity: a systematic review and meta-analysis of randomized clinical trials
Khalafi M, Sakhaei MH, Kazeminasab F, et al.
NMCD. Pub. online 23 May 2023.
Leggi
Concurrence of hyperinsulinemia and hyperuricemia significantly augmented all-cause mortality
Acevedo-Fernández M, Porchia LM, Garazi Elguezabal-Rodelo R, et al.
NMCD. Pub. online 23 May 2023.
Leggi
MOTORE SANITÀ – Accesso regionale alle terapie innovative in Piemonte, il punto sul diabete | 29 maggio 2023
Leggi
Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study
Hu J, Fang M, Pike JR, et al.
Diabetologia. Pub. online 24 May 2023.
Leggi
The bidirectional relationship between NAFLD and type 2 diabetes: a prospective population-based cohort study
Wang M, Zhao Y, He Y et, al.
NMCD. Pub. online 16 May 2023.
Leggi
Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trial
Wexler DJ, de Boer IH, Ghosh A, et al.
JAMA Intern Med. 2023;e231487.
Leggi
Kidney protection with canagliflozin: a combined analysis of the randomized CANVAS program and CREDENCE trials
Sridhar VS, Neuen BL, Fletcher RA, et al.
Diabetes Obes Metab. Pub. online 15 May 2023.
Leggi